Active Awards Portfolio Dashboard
It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and clinical stage research. Check out our portfolio of active research awards in our interactive dashboard below. For a detailed list of CIRM-funded clinical trials, visit our Clinical Trials Dashboard.

Filter Awards
Disease![]() |
Cell Type | Therapeutic or Technology | Institution | Stage | Project Objective | Details |
---|---|---|---|---|---|---|
COVID-19 |
Embryonic Stem Cell, iPS Cell |
Gene-modified, donor cell therapy | COH |
![]() |
Proof of Concept | |
COVID-19 | iPS Cell | Small molecule therapy | USC |
![]() |
Development Candidate, Proof of Concept | |
Cystinosis, Kidney Failure |
Adult Stem Cell | Gene-modified, personalized cell therapy | UCSD |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Dementia | iPS Cell | Donor cell therapy | Gladstone |
![]() |
Development Candidate, Proof of Concept | |
Epidermolysis Bullosa | iPS Cell | Gene-modified, personalized cell therapy | Stanford |
![]() |
Pre-IND/IDE or Equivalent | |
Epilepsy | Embryonic Stem Cell | Donor cell therapy | Neurona Therapeutics |
![]() |
Pre-IND/IDE or Equivalent | |
Epilepsy | Embryonic Stem Cell | Donor cell therapy | Neurona Therapeutics |
![]() |
Research Insights | |
Hearing Loss | iPS Cell | Model system development | USC |
![]() |
Proof of Concept, Tool/Resources/Bottleneck | |
Hearing Loss | Adult Stem Cell | Protein/peptide therapy | Stanford |
![]() |
Development Candidate, Proof of Concept | |
Hemophilia A | Adult Stem Cell | Gene modification | COH |
![]() |
Development Candidate, Proof of Concept | |
HIV-related Lymphoma, HIV/AIDS |
Adult Stem Cell | Gene-modified, personalized cell therapy | UC Davis |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
HIV/AIDS, Immune Disease |
Adult Stem Cell | Gene-modified, personalized cell therapy | UCSF |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
HIV/AIDS | Adult Stem Cell | Gene-modified, personalized cell therapy | COH |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
HIV/AIDS | Personalized cell therapy | COH |
![]() |
IND | ||
Huntington's Disease | Embryonic Stem Cell | Donor cell therapy | UC Irvine |
![]() |
IND | |
Hyper IgM Syndrome, Immune Disease |
Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
![]() |
Pre-IND/IDE or Equivalent | |
Immune Disease, Leukocyte Adhesion Deficiency |
Adult Stem Cell | Gene-modified, personalized cell therapy | Rocket Pharmaceuticals, Inc. |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Immune Disease, Severe Combined Immunodeficiency, X-linked (X-SCID) |
Adult Stem Cell | Gene-modified, personalized cell therapy | St. Jude |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Immune Disease, Severe Combined Immunodeficiency, Adenosine deaminase-deficient (ADA-SCID) |
Adult Stem Cell | Gene-modified, personalized cell therapy | Orchard Therapeutics |
![]() |
Clinical Trial, Phase 2 | |
Immune Disease, X-linked Chronic Granulomatous Disease |
Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Inflammatory bowel disease | Adult Stem Cell | Donor cell therapy | Vitabolus, Inc. |
![]() |
Development Candidate, Proof of Concept | |
Intestinal Disease, Neurological Disorders |
iPS Cell | Donor cell therapy | CHLA |
![]() |
Pre-IND/IDE or Equivalent | |
IPEX Syndrome, Immune Disease |
Vital Research Opportunity | Gene Therapy, cell free | Stanford |
![]() |
IND | |
Kidney Failure | Adult Stem Cell | Donor cell therapy | Stanford |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Kidney Failure | Adult Stem Cell | Donor cell therapy | Stanford |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Kidney Failure | Adult Stem Cell | Donor cell therapy | Medeor Therapeutics |
![]() |
Clinical Trial, Phase 3 | |
Leukemia | Cancer Stem Cell | Gene-modified, personalized cell therapy | UCSD |
![]() |
Pre-IND/IDE or Equivalent | |
Leukemia, Acute Myeloid (AML), Multiple Myeloma |
Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
![]() |
Pre-IND/IDE or Equivalent | |
Leukemia, Acute Myeloid (AML) | Cancer Stem Cell | Small molecule therapy | UCSD |
![]() |
Pre-IND/IDE or Equivalent | |
Leukemia, Acute Myeloid (AML) | Embryonic Stem Cell | Donor cell therapy | UCSD |
![]() |
Pre-IND/IDE or Equivalent | |
Leukemia, Acute Myeloid (AML) | Cancer Stem Cell | Gene-modified, personalized cell therapy | UCSF |
![]() |
Pre-IND/IDE or Equivalent | |
Liver Disease | iPS Cell | Gene-modified, donor cell therapy | CHLA |
![]() |
Development Candidate, Proof of Concept | |
Lung Cancer | Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Multiple Myeloma | Adult Stem Cell | Gene-modified, personalized cell therapy | Poseida Therapeutics |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Multiple Myeloma | Adult Stem Cell | Personalized cell therapy | UCLA |
![]() |
Pre-IND/IDE or Equivalent | |
Skeletal/Smooth Muscle disorders | Adult Stem Cell | Small molecule therapy | Stanford |
![]() |
Proof of Concept | |
Neurological Disorders | Embryonic Stem Cell | Donor cell therapy | UC Irvine |
![]() |
Development Candidate, Proof of Concept | |
Osteonecrosis | Adult Stem Cell | Small molecule therapy | UC Davis |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Ovarian Cancer | Adult Stem Cell | Gene-modified, personalized cell therapy | COH |
![]() |
Development Candidate, Proof of Concept | |
Ovarian Cancer | Adult Stem Cell | Gene-modified, donor cell therapy | COH |
![]() |
Pre-IND/IDE or Equivalent | |
Ovarian Cancer | iPS Cell | Gene-modified, donor cell therapy | UCSD |
![]() |
Development Candidate, Proof of Concept | |
Parkinson's Disease | Adult Stem Cell | Gene-modified, donor cell therapy | UCSF |
![]() |
IND | |
Parkinson's Disease | Vital Research Opportunity | Gene Therapy, cell free | Brain Neurotherapy Bio |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Parkinson's Disease | iPS Cell | Cell processing & handling | Aspen Neuroscience | Research Insights, Tool/Resources/Bottleneck | ||
Pulmonary Hypertension, Vascular Disease |
Adult Stem Cell | Donor cell therapy | Cedars-Sinai |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Retinitis Pigmentosa | Therapeutic Approach | jCyte |
![]() |
Clinical Trial, Phase 2 | ||
Retinitis Pigmentosa | Adult Stem Cell | Donor cell therapy | Cedars-Sinai |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Retinitis Pigmentosa | Other | Donor cell therapy | jCyte |
![]() |
Clinical Trial, Phase 2 | |
Retinitis Pigmentosa | Embryonic Stem Cell | Donor cell therapy | UC Irvine |
![]() |
Pre-IND/IDE or Equivalent | |
Sarcoma | Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 |